Following the passing of the Dodd-Frank legislation, the CFTC is at work defining new regulations that will place additional requirements on all parties who transact in over the counter (OTC) derivatives. Structure is offering an informative, free Executive Briefing to discuss the effect of these changes on your risk management strategy, compliance program, IT infrastructure, reporting capabilities, and your ability to keep up with ongoing regulatory changes.

This Executive Briefing is relevant for all organizations who transact in OTC derivatives. Those who will find it particularly relevant may be pondering any or all of the following questions:

• How will we expect to be classified under Dodd-Frank (Swap Dealer, Major Swap Participant, or end-user)?
• Have we evaluated how the coming regulations will affect the costs and responsibilities associated with my derivatives activity?
• What information may need to be reported, how frequently, and do we presently capture it?

Structure has a deep understanding of the Dodd-Frank legislation and ongoing rulemaking and is an industry-recognized expert in the systems that will help support compliance with the coming requirements. If you use swaps and would like to discuss the effects of the regulations on your organization, contact us today for this limited-time offer!